SymBio Pharmaceuticals Limited
SYMQY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,963,580 | $6,517,007 | $6,282,554 | $3,860,106 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $423,153 | $30 | $2,084,915 | $2,147,510 |
| Inventory | $238,919 | $232,000 | $469,379 | $385,684 |
| Other Curr. Assets | $298,579 | $1,333,489 | $475,858 | $354,538 |
| Total Curr. Assets | $4,924,231 | $8,082,526 | $9,312,706 | $6,747,838 |
| Property Plant & Equip (Net) | $44,102 | $87,716 | $153,709 | $170,295 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $222,204 | $259,104 |
| Long-Term Investments | $0 | $87,000 | $85,000 | -$86,660 |
| Tax Assets | $0 | $0 | $744,728 | $1,275,759 |
| Other NC Assets | $0 | -$87,000 | -$85,000 | $86,660 |
| Total NC Assets | $44,102 | $87,716 | $1,120,641 | $1,705,158 |
| Other Assets | $0 | $1 | $0 | $1 |
| Total Assets | $4,968,333 | $8,170,243 | $10,433,347 | $8,452,997 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $46,633 | $69,683 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $102,006 | $18,474 | $401,066 | $899,635 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $664,163 | $938,151 | $1,476,171 | $548,793 |
| Total Curr. Liab. | $766,169 | $956,625 | $1,923,870 | $1,518,111 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $6,994,722 | $6,723,655 |
| Other NC Liab. | $4,605 | $3,708 | $3,386 | $189,213 |
| Total NC Liab. | $4,605 | $3,708 | $3,386 | $189,213 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $770,774 | $960,333 | $1,927,256 | $1,707,324 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $18,336,841 | $17,952,000 | $17,548,459 | $17,157,628 |
| Retained Earnings | -$32,685,784 | -$28,852,303 | -$26,889,486 | -$27,977,510 |
| AOCI | $0 | $0 | $411,915 | $519,099 |
| Other Equity | $18,546,502 | $18,110,213 | $17,847,118 | $17,565,555 |
| Total Equity | $4,197,559 | $7,209,910 | $8,506,091 | $6,745,673 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,968,333 | $8,170,243 | $10,433,347 | $8,452,997 |
| Net Debt | -$3,963,580 | -$6,517,007 | -$6,282,554 | -$3,860,106 |